ABX-IL8: Completed Phase I/II study

Abgenix Inc. (ABGX), Fremont, Calif. Product: ABX-IL8 Business: Autoimmune/Inflammation Therapeutic category: Antibody Target: IL-8 Description: Human monoclonal antibody against interleukin-8 (IL-8) ...